Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma
- 30 November 1995
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 96 (5) , 661-668
- https://doi.org/10.1016/s0091-6749(95)70265-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Eosinophil survival activity identified as interleukin-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-four hours after segmental antigen lung challengeJournal of Allergy and Clinical Immunology, 1993
- Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.Journal of Clinical Investigation, 1992
- Cytokines in symptomatic asthma airwaysJournal of Allergy and Clinical Immunology, 1992
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airwayJournal of Allergy and Clinical Immunology, 1991
- Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.Journal of Clinical Investigation, 1991
- In vivoadministration of antibody to murine IL-5 receptor inhibits eosinophilia of IL-5 transgenic miceInternational Immunology, 1991
- Eosinophilia in transgenic mice expressing interleukin 5.The Journal of Experimental Medicine, 1990
- Antibody to Interleukin-5 Inhibits Helminth-Induced Eosinophilia in MiceScience, 1989
- Recombinant human interleukin 5 is a selective activator of human eosinophil function.The Journal of Experimental Medicine, 1988